Rare Cutaneous Malignancies in Skin of Color

Dermatol Surg. 2022 Jun 1;48(6):606-612. doi: 10.1097/DSS.0000000000003440. Epub 2022 Apr 6.

Abstract

Background: There is a scarcity of information regarding the clinical characteristics of rare cutaneous malignancies in skin of color that has yet to be comprehensively explored.

Objective: To review and compile the racial differences in epidemiology, clinical presentation, histology, treatments, and outcomes of 3 rare skin cancers: dermatofibrosarcoma protuberans (DFSP), Merkel cell carcinoma (MCC), and sebaceous carcinoma (SC).

Methods: Several searches with keywords denoting specific skin cancer type and race were conducted on PubMed to complete this narrative review.

Results: We analyzed 50 sources that were relevant to the initial objective.

Conclusion: The literature demonstrates that there are nuances in DFSP, MCC, and SC unique to African Americans, Asians/Pacific Islanders, and Hispanics that may differ significantly from Caucasian counterparts. African Americans consistently suffer from the worst clinical outcomes in all 3 rare cutaneous malignancies reviewed. Greater physician awareness and knowledge of the discussed racial differences is the preliminary step to address these disparities.

Publication types

  • Review

MeSH terms

  • Carcinoma, Merkel Cell* / epidemiology
  • Carcinoma, Merkel Cell* / therapy
  • Dermatofibrosarcoma* / epidemiology
  • Dermatofibrosarcoma* / pathology
  • Dermatofibrosarcoma* / therapy
  • Humans
  • Racial Groups
  • Sebaceous Gland Neoplasms*
  • Skin Neoplasms* / epidemiology
  • Skin Neoplasms* / pathology
  • Skin Neoplasms* / therapy